Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
• Print ISBN: 9781719648035
eText ISBN:9781719651585
,Question 1
A family nurse practitioner is preparing to prescribe an
antihypertensive medication for a newly diagnosed patient.
Before issuing the prescription, the APRN reviews the patient's
medical history, allergies, laboratory results, and current
medications. Which prescribing principle is MOST consistent
with safe evidence-based practice?
A. Select the newest medication available because it is likely to
be more effective.
B. Prescribe the medication with the lowest acquisition cost
regardless of patient factors.
C. Individualize therapy after evaluating patient-specific risks,
benefits, and therapeutic goals.
D. Begin treatment with the highest recommended dose to
achieve rapid blood pressure control.
Correct Answer: C
Rationale: Safe prescribing requires individualized assessment
that incorporates the patient's diagnosis, comorbidities,
concurrent medications, allergies, laboratory findings,
treatment goals, and preferences. Newer medications are not
automatically superior, lower cost should not override clinical
,appropriateness, and initiating therapy with the highest dose
unnecessarily increases adverse-effect risk.
Question 2
A mixed APRN practice receives a pharmaceutical
representative promoting a recently approved medication. The
representative provides free samples and promotional
literature claiming superior efficacy. Which action best reflects
professional prescribing responsibility?
A. Prescribe the medication routinely because FDA approval
confirms superiority.
B. Base prescribing decisions primarily on promotional
materials.
C. Critically evaluate independent evidence before
incorporating the medication into practice.
D. Offer the medication to all eligible patients before reviewing
post-marketing safety data.
Correct Answer: C
Rationale: APRNs should critically appraise independent
evidence, guideline recommendations, safety data, and
comparative effectiveness before adopting new therapies. FDA
approval establishes safety and efficacy for approved
indications but does not demonstrate superiority over existing
, therapies. Promotional materials should never replace
independent evidence.
Question 3
An APRN is evaluating a patient before prescribing an oral
antimicrobial agent. Which additional information is MOST
important to obtain before selecting therapy?
A. Patient's favorite pharmacy
B. Current prescription, over-the-counter, and herbal
medications
C. Preferred appointment time
D. Health insurance deductible
Correct Answer: B
Rationale: Medication reconciliation is a fundamental
component of safe prescribing because potential drug-drug
interactions, duplicate therapies, and herbal supplement
interactions may significantly influence medication selection.
Pharmacy preference and insurance considerations are
important operational issues but do not supersede patient
safety.
Question 4
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
• Print ISBN: 9781719648035
eText ISBN:9781719651585
,Question 1
A family nurse practitioner is preparing to prescribe an
antihypertensive medication for a newly diagnosed patient.
Before issuing the prescription, the APRN reviews the patient's
medical history, allergies, laboratory results, and current
medications. Which prescribing principle is MOST consistent
with safe evidence-based practice?
A. Select the newest medication available because it is likely to
be more effective.
B. Prescribe the medication with the lowest acquisition cost
regardless of patient factors.
C. Individualize therapy after evaluating patient-specific risks,
benefits, and therapeutic goals.
D. Begin treatment with the highest recommended dose to
achieve rapid blood pressure control.
Correct Answer: C
Rationale: Safe prescribing requires individualized assessment
that incorporates the patient's diagnosis, comorbidities,
concurrent medications, allergies, laboratory findings,
treatment goals, and preferences. Newer medications are not
automatically superior, lower cost should not override clinical
,appropriateness, and initiating therapy with the highest dose
unnecessarily increases adverse-effect risk.
Question 2
A mixed APRN practice receives a pharmaceutical
representative promoting a recently approved medication. The
representative provides free samples and promotional
literature claiming superior efficacy. Which action best reflects
professional prescribing responsibility?
A. Prescribe the medication routinely because FDA approval
confirms superiority.
B. Base prescribing decisions primarily on promotional
materials.
C. Critically evaluate independent evidence before
incorporating the medication into practice.
D. Offer the medication to all eligible patients before reviewing
post-marketing safety data.
Correct Answer: C
Rationale: APRNs should critically appraise independent
evidence, guideline recommendations, safety data, and
comparative effectiveness before adopting new therapies. FDA
approval establishes safety and efficacy for approved
indications but does not demonstrate superiority over existing
, therapies. Promotional materials should never replace
independent evidence.
Question 3
An APRN is evaluating a patient before prescribing an oral
antimicrobial agent. Which additional information is MOST
important to obtain before selecting therapy?
A. Patient's favorite pharmacy
B. Current prescription, over-the-counter, and herbal
medications
C. Preferred appointment time
D. Health insurance deductible
Correct Answer: B
Rationale: Medication reconciliation is a fundamental
component of safe prescribing because potential drug-drug
interactions, duplicate therapies, and herbal supplement
interactions may significantly influence medication selection.
Pharmacy preference and insurance considerations are
important operational issues but do not supersede patient
safety.
Question 4
